Mirna Therapeutics (MIRN) Says FDA Placed MRX34 IND on Full Clinical Hold
Tweet Send to a Friend
Mirna Therapeutics (NASDAQ: MIRN) disclosed the following on Thursday:Item 8.01 Other Events.On September 28, 2016, Mirna Therapeutics, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
